Logo image of MOH

MOLINA HEALTHCARE INC (MOH) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:MOH - US60855R1005 - Common Stock

192.405 USD
-1.34 (-0.69%)
Last: 1/16/2026, 2:45:06 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MOH. MOH was compared to 100 industry peers in the Health Care Providers & Services industry. MOH has only an average score on both its financial health and profitability. MOH has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • MOH had positive earnings in the past year.
  • In the past year MOH has reported a negative cash flow from operations.
  • Each year in the past 5 years MOH has been profitable.
  • MOH had a positive operating cash flow in each of the past 5 years.
MOH Yearly Net Income VS EBIT VS OCF VS FCFMOH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.62%, MOH is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 21.07%, MOH belongs to the top of the industry, outperforming 88.00% of the companies in the same industry.
  • MOH has a better Return On Invested Capital (11.98%) than 86.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for MOH is significantly above the industry average of 9.19%.
  • The 3 year average ROIC (17.96%) for MOH is well above the current ROIC(11.98%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.62%
ROE 21.07%
ROIC 11.98%
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
MOH Yearly ROA, ROE, ROICMOH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • The Profit Margin of MOH (1.98%) is better than 61.00% of its industry peers.
  • In the last couple of years the Profit Margin of MOH has declined.
  • MOH has a Operating Margin (2.97%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of MOH has declined.
  • MOH has a worse Gross Margin (13.91%) than 66.00% of its industry peers.
  • In the last couple of years the Gross Margin of MOH has declined.
Industry RankSector Rank
OM 2.97%
PM (TTM) 1.98%
GM 13.91%
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
MOH Yearly Profit, Operating, Gross MarginsMOH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MOH is creating value.
  • MOH has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for MOH has been reduced compared to 5 years ago.
  • MOH has a worse debt/assets ratio than last year.
MOH Yearly Shares OutstandingMOH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MOH Yearly Total Debt VS Total AssetsMOH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • MOH has an Altman-Z score of 4.36. This indicates that MOH is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.36, MOH is in the better half of the industry, outperforming 77.00% of the companies in the same industry.
  • MOH has a Debt/Equity ratio of 0.92. This is a neutral value indicating MOH is somewhat dependend on debt financing.
  • MOH's Debt to Equity ratio of 0.92 is in line compared to the rest of the industry. MOH outperforms 41.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Altman-Z 4.36
ROIC/WACC1.42
WACC8.45%
MOH Yearly LT Debt VS Equity VS FCFMOH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.68 indicates that MOH should not have too much problems paying its short term obligations.
  • The Current ratio of MOH (1.68) is better than 65.00% of its industry peers.
  • A Quick Ratio of 1.68 indicates that MOH should not have too much problems paying its short term obligations.
  • MOH has a better Quick ratio (1.68) than 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.68
MOH Yearly Current Assets VS Current LiabilitesMOH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

  • MOH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.06%.
  • The Earnings Per Share has been growing by 14.16% on average over the past years. This is quite good.
  • MOH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.65%.
  • MOH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.29% yearly.
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%

3.2 Future

  • MOH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.04% yearly.
  • The Revenue is expected to grow by 6.09% on average over the next years.
EPS Next Y-36.42%
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
EPS Next 5Y5.04%
Revenue Next Year10.79%
Revenue Next 2Y7.48%
Revenue Next 3Y7.21%
Revenue Next 5Y6.09%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MOH Yearly Revenue VS EstimatesMOH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
MOH Yearly EPS VS EstimatesMOH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20 30 40

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.43 indicates a reasonable valuation of MOH.
  • 91.00% of the companies in the same industry are more expensive than MOH, based on the Price/Earnings ratio.
  • MOH is valuated cheaply when we compare the Price/Earnings ratio to 27.54, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 14.06, MOH is valued correctly.
  • 84.00% of the companies in the same industry are more expensive than MOH, based on the Price/Forward Earnings ratio.
  • MOH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.31, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.43
Fwd PE 14.06
MOH Price Earnings VS Forward Price EarningsMOH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • MOH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MOH is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.75
MOH Per share dataMOH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

  • MOH has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as MOH's earnings are expected to decrease with -10.35% in the coming years.
PEG (NY)N/A
PEG (5Y)0.74
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%

0

5. Dividend

5.1 Amount

  • MOH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MOLINA HEALTHCARE INC

NYSE:MOH (1/16/2026, 2:45:06 PM)

192.405

-1.34 (-0.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-22
Earnings (Next)02-05
Inst Owners113.06%
Inst Owner Change0.37%
Ins Owners1.33%
Ins Owner Change1.17%
Market Cap9.89B
Revenue(TTM)44.55B
Net Income(TTM)883.00M
Analysts56.3
Price Target172.29 (-10.45%)
Short Float %7.14%
Short Ratio1.98
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.8%
Min EPS beat(2)-53.34%
Max EPS beat(2)-6.27%
EPS beat(4)1
Avg EPS beat(4)-17.79%
Min EPS beat(4)-53.34%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-7.75%
EPS beat(12)8
Avg EPS beat(12)-3.04%
EPS beat(16)12
Avg EPS beat(16)-1.32%
Revenue beat(2)2
Avg Revenue beat(2)3.64%
Min Revenue beat(2)3.29%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)2.53%
Min Revenue beat(4)0.69%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)3.12%
Revenue beat(12)10
Avg Revenue beat(12)2.26%
Revenue beat(16)14
Avg Revenue beat(16)2.23%
PT rev (1m)-1.2%
PT rev (3m)-16.03%
EPS NQ rev (1m)-34.65%
EPS NQ rev (3m)-89.71%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)-23.58%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-0.89%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.73%
Valuation
Industry RankSector Rank
PE 10.43
Fwd PE 14.06
P/S 0.22
P/FCF N/A
P/OCF N/A
P/B 2.36
P/tB 4.97
EV/EBITDA 0.75
EPS(TTM)18.45
EY9.59%
EPS(NY)13.69
Fwd EY7.11%
FCF(TTM)-11.17
FCFYN/A
OCF(TTM)-8.97
OCFYN/A
SpS866.73
BVpS81.54
TBVpS38.7
PEG (NY)N/A
PEG (5Y)0.74
Graham Number183.98
Profitability
Industry RankSector Rank
ROA 5.62%
ROE 21.07%
ROCE 16.11%
ROIC 11.98%
ROICexc N/A
ROICexgc N/A
OM 2.97%
PM (TTM) 1.98%
GM 13.91%
FCFM N/A
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)24.15%
ROCE(5y)23.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
F-Score4
Asset Turnover2.84
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Debt/EBITDA 2.53
Cap/Depr 56.78%
Cap/Sales 0.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1.68
Altman-Z 4.36
F-Score4
WACC8.45%
ROIC/WACC1.42
Cap/Depr(3y)51.53%
Cap/Depr(5y)59.49%
Cap/Sales(3y)0.26%
Cap/Sales(5y)0.29%
Profit Quality(3y)92.3%
Profit Quality(5y)171.56%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
EPS Next Y-36.42%
EPS Next 2Y-22.26%
EPS Next 3Y-10.35%
EPS Next 5Y5.04%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
Revenue Next Year10.79%
Revenue Next 2Y7.48%
Revenue Next 3Y7.21%
Revenue Next 5Y6.09%
EBIT growth 1Y-19.56%
EBIT growth 3Y15.28%
EBIT growth 5Y10.22%
EBIT Next Year-31.25%
EBIT Next 3Y-9.54%
EBIT Next 5Y3.97%
FCF growth 1Y-128.12%
FCF growth 3Y-35.66%
FCF growth 5Y7.61%
OCF growth 1Y-121.54%
OCF growth 3Y-32.77%
OCF growth 5Y8.21%

MOLINA HEALTHCARE INC / MOH FAQ

Can you provide the ChartMill fundamental rating for MOLINA HEALTHCARE INC?

ChartMill assigns a fundamental rating of 5 / 10 to MOH.


What is the valuation status of MOLINA HEALTHCARE INC (MOH) stock?

ChartMill assigns a valuation rating of 5 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Fairly Valued.


How profitable is MOLINA HEALTHCARE INC (MOH) stock?

MOLINA HEALTHCARE INC (MOH) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for MOH stock?

The Price/Earnings (PE) ratio for MOLINA HEALTHCARE INC (MOH) is 10.43 and the Price/Book (PB) ratio is 2.36.